Sophie Raynaud

Hôpital Pasteur — France

Medicine · Health Sciences

34h-index4.4kcitations193works6.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(83), Chronic Lymphocytic Leukemia Research(54), Chronic Myeloid Leukemia Treatments(47), Myeloproliferative Neoplasms: Diagnosis and Treatment(31), Lymphoma Diagnosis and Treatment(20)

Publications193 total

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia
Blood·2026Open Access
Prognostic impact of genetic abnormalities in 536 first‐line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV‐mutated subgroups (a <scp>FILO</scp> study)
British Journal of Haematology·2024· 4 citedOpen Access
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation
Nature Communications·2024· 15 citedOpen Access
QuiDitQuoi, un lieu d’accueil pour les enfants de 3 à 6 ans et leurs parents
Le Coq-héron·2023
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment‐free remission period after imatinib discontinuation: Results of the French Nilo post‐<scp>STIM</scp> study
British Journal of Haematology·2023· 16 citedOpen Access
Supplementary Figure 4 from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Supplementary Figure Legends 1-6 from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Data from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Supplementary Materials and Methods from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Supplementary Figure Legends 1-6 from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Data from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Supplementary Figure 3 from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Supplementary Methods from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Supplementary Figures 1-6 from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Supplementary Figures 1-6 from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Supplementary Methods from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
2023Open Access
Supplementary Figure 2 from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
Supplementary Figure 1 from Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Thomas Cluzeau(11), Patrick Auberger(10), Guillaume Robert(9), Alexandre Puissant(7), Christian Bastard(7), Claude Preudhomme(6), Frédéric Luciano(6), Arnaud Jacquel(6), Pierre Fenaux(5), Maeva Dufies(5), Reynald Hocquemiller(5), Josiane Grosgeorge(4), François Dreyfus(4), Norbert Vey(4), Lionel Adès(4), Nina Fenouille(4), Jill‐Patrice Cassuto(4), H. Phillip Koeffler(4), J.P. Cassuto(4), Stéphanie Struski(4)